Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sesame Care vs Better MedSpa

Two GLP-1 desks, one scoreboard. We put Sesame Care and Better MedSpa head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 4 · Grade B+

Sesame Care

Visit Sesame Care Full brief →
vs
No. 432 · Grade C

Better MedSpa

Visit Better MedSpa Full brief →

The verdict

Sesame Care takes this head-to-head.

Sesame Care scores 87 to 52 on our six-factor Brief Score — An established national telehealth marketplace with the widest real brand-name GLP-1 access on the board — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

That doesn't make Better MedSpa a bad call — it's best for readers who want illinois residents wanting physician-led glp-1 weight loss with in-person or telehealth options. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
40
Supply Reliability
92
70
Transparency
94
23
Access Breadth
84
42
Clinical Oversight
80
77
Track Record
92
70
Sesame CareBrief Score 87 · 52Better MedSpa

Price, coverage & the tracker

Sesame CareBetter MedSpa
Brief Score87/100 (B+)52/100 (C)
SemaglutideFrom $149/mo (brand Wegovy pill)Not disclosed
TirzepatideBrand Zepbound (price varies)Not disclosed
CoverageNationwide marketplace1 states
Brand-name accessYesCompounded only
Oral / sublingualYesYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

Sesame Care: Marketplace pricing is set per provider rather than one desk rate; the brand-name Wegovy pill line held its ~$149 entry this cycle.

Better MedSpa: New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.